Non-steroidal Anti-inflammatory Drugs （
Market
NSAID ）
Non-steroidal Anti-inflammatory Drugs （ NSAID ）
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Non-steroidal Anti-inflammatory Drugs
Market Size and Growth
NSAID
The Non-steroidal Anti-inflammatory Drugs (NSAID) market is experiencing significant growth, driven by increasing chronic pain prevalence and rising demand for pain management solutions. The global NSAID market size is projected to reach approximately $36 billion by 2028, reflecting robust market conditions and ongoing innovations in drug formulations and delivery methods.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Bayer
◍ Novacap
◍ Abbott
◍ Pfizer
◍ Geri-Care Pharmaceuticals
◍ Perrigo Company
◍ Kopran
◍ Merck Sharp & Dohme
◍ Sun Pharmaceutical Industries
◍ Glaxo Smith Kline
◍ Reddy Pharmaceuticals
◍ Johnson & Johnson
The NSAID market features major players like Bayer, Pfizer, and Johnson & Johnson, focusing on innovative formulations and strategic partnerships. Companies contribute to market growth by enhancing product accessibility, investing in R&D, and broadening therapeutic applications. Sales figures include:
- Pfizer: ~$51 billion (2022)
- Johnson & Johnson: ~$93 billion (2022)
Request Sample Report
Market Segmentation
By Application
Back Pain Treatment
Osteoarthritis Treatment
Other
Request Sample Report
By Product
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Market Growth
Request Sample Report
$ X Billion USD
